CAT # | Sunan samfur | Bayani |
Saukewa: CPD0004 | Ertugliflozin | Ertugliflozin, wanda kuma aka sani da PF-04971729, mai ƙarfi ne kuma mai zaɓin mai hanawa na 2 mai dogaro da sodium da kuma ɗan takarar asibiti don kula da nau'in ciwon sukari na 2. |
Saukewa: CPDA0048 | Umargliptin | Omarigliptin, wanda kuma aka sani da MK-3102, mai ƙarfi ne kuma mai hana DPP-4 mai tsayi don maganin ciwon sukari na 2 na mako-mako sau ɗaya. |
Saukewa: CPDA1089 | Retagliptin | Retagliptin, wanda kuma aka sani da SP-2086, mai hana DPP-4 ne mai yuwuwar amfani da shi don kula da nau'in ciwon sukari na 2. |
Saukewa: CPDA0088 | Trelagliptin | Trelagliptin, wanda kuma aka sani da SYR-472, shine mai hana dipeptidyl peptidase-4 (DPP-4) mai tsayi wanda Takeda ke haɓakawa don maganin ciwon sukari na 2 (T2D). |
Saukewa: CPDA2039 | Linagliptin | Linagliptin, wanda kuma aka sani da BI-1356, mai hana DPP-4 ne wanda Boehringer Ingelheim ya haɓaka don kula da nau'in ciwon sukari na II. |
Saukewa: CPDA0100 | Sitagliptin | Sitagliptin (INN; wanda aka fi sani da MK-0431 kuma ana siyarwa a ƙarƙashin sunan kasuwanci Januvia) maganin antihyperglycemic na baka (maganin ciwon sukari) na aji inhibitor dipeptidyl peptidase-4 (DPP-4). |
Saukewa: CPD0854 | LX-4211 | LX-4211 mai karfin dual SGLT2/1 mai hanawa; Magungunan maganin ciwon sukari. |
Saukewa: CPDA1553 | LX-2761 | LX2761 mai hanawa SGLT1 ne a cikin gida wanda ke da ƙarfi sosai a cikin vitro kuma yana jinkirta sha glucose na hanji a cikin vivo don haɓaka sarrafa glycemic. |